magnesium sulfate has been researched along with Encephalopathy, Toxic in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ausseil, J; Cleren, C; Daher, I; Daumas, S; Dourmap, N; El Mestikawy, S; Gomila, C; Gonzalez, B; Le Dieu-Lugon, B; Lecuyer, M; Leroux, P; Leroux-Nicollet, I; Marret, S; Ramet, L; Roy, V | 1 |
Ayerden, T; Dikmen, B; Ornek, D; Ozdogan, L; Postaci, A; Sastim, H | 1 |
Atkins, CD | 1 |
Clara, A; Drüge, G; Felgenhauer, N; Rauch, S; Überbacher, CA | 1 |
Dong, M; Feng, FY; Liu, P; Shi, YK; Xing, PY | 1 |
Chay, WY; Choo, SP; Gao, F; Koo, WH; Lo, YL; Ng, HC; Ong, SY; Tan, SH | 1 |
Alberts, SR; Chitaley, U; Dentchev, T; Grothey, A; Kugler, JW; Loprinzi, CL; Nikcevich, DA; Novotny, PJ; Silberstein, PT; Sloan, JA; Wender, DB | 1 |
Chan, A; Chay, WY; Chiang, J; Lew, KY | 1 |
3 trial(s) available for magnesium sulfate and Encephalopathy, Toxic
Article | Year |
---|---|
[Assessment of the protective effect of calcium-magnesium infusion and glutathione on oxaliplatin-induced neurotoxicity].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Calcium Gluconate; Colorectal Neoplasms; Double-Blind Method; Drug Therapy, Combination; Female; Fluorouracil; Glutathione; Humans; Infusions, Intravenous; Leucovorin; Magnesium Sulfate; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Stomach Neoplasms; Young Adult | 2010 |
Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcium Gluconate; Capecitabine; Cohort Studies; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Magnesium Sulfate; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Calcium Gluconate; Chemotherapy, Adjuvant; Chi-Square Distribution; Colonic Neoplasms; Double-Blind Method; Drug Combinations; Early Termination of Clinical Trials; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Sensation Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2011 |
5 other study(ies) available for magnesium sulfate and Encephalopathy, Toxic
Article | Year |
---|---|
Magnesium Sulfate Prevents Neurochemical and Long-Term Behavioral Consequences of Neonatal Excitotoxic Lesions: Comparison Between Male and Female Mice.
Topics: Aging; Animals; Animals, Newborn; Brain; Calcium Channel Blockers; Disease Models, Animal; Excitatory Amino Acid Agonists; Female; Functional Laterality; Gait Disorders, Neurologic; gamma-Aminobutyric Acid; Glutamic Acid; Ibotenic Acid; Longitudinal Studies; Magnesium Sulfate; Male; Mice; Motor Skills; Neurotoxicity Syndromes; Sex Factors; Vesicular Glutamate Transport Protein 1 | 2017 |
Neurotoxic effects of intrathecal magnesium sulphate.
Topics: Animals; Anticonvulsants; Injections, Spinal; Magnesium Sulfate; Neurodegenerative Diseases; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley | 2013 |
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium; Calcium Gluconate; Colonic Neoplasms; Female; Humans; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Peripheral Nervous System Diseases; Sensation Disorders | 2014 |
[High-dose magnesium sulfate in the treatment of aconite poisoning].
Topics: Aconitum; Alkaloids; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Heart Diseases; Humans; Magnesium Sulfate; Male; Middle Aged; Neurotoxicity Syndromes; Sodium Channel Agonists; Sodium Channels; Suicide, Attempted; Tachycardia; Veratrum | 2015 |
Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective.
Topics: Adenocarcinoma; Antineoplastic Agents; Calcium Gluconate; Clinical Trials as Topic; Colonic Neoplasms; Early Termination of Clinical Trials; Humans; Infusions, Intravenous; Magnesium Sulfate; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Research Design; Sensory Receptor Cells | 2011 |